top of page
    • Jun 27

Spinal Cord Injury Investment Symposium: The Co-Founder and CEO of NeuroHagana discusses the role that glutamate excitotoxicity plays in neurotrama injury

Angela Ruban describes how NeuroHagana is developing a treatment to lower blood glutamate levels that she believes would ideally be administered as quickly after acute injury as possible.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

@BiotechTVHQ

BiotechTV

BiotechTVHQ

@BiotechTV

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Theragent_Logo-Landscape_red-small.png

Theragent is an advanced therapeutics Contract Development Manufacturing Organization in Arcadia, CA, focused on novel cell and gene therapies for the treatment of cancer and rare diseases. The company’s innovative cGMP facility offers comprehensive end-to-end manufacturing and in-house testing capabilities for clinical and commercial purposes. 

Visit Theragent

bottom of page